Back to Search
Start Over
Imatinib resistance in chronic myeloid leukemia due to a rare mutation.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2017 Jul; Vol. 58 (7), pp. 1750-1752. Date of Electronic Publication: 2016 Nov 20. - Publication Year :
- 2017
- Subjects :
- Adult
Alleles
Cell Line, Tumor
DNA Mutational Analysis
Fusion Proteins, bcr-abl chemistry
Humans
Male
Antineoplastic Agents pharmacology
Drug Resistance, Neoplasm genetics
Fusion Proteins, bcr-abl genetics
Imatinib Mesylate pharmacology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Mutation
Protein Kinase Inhibitors pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 58
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Report
- Accession number :
- 27868464
- Full Text :
- https://doi.org/10.1080/10428194.2016.1256479